Drive increased political support to increase investments in new vaccines, medicines and diagnostics.

Actively promote the existing and innovative financing models for global health research (R&D) and delivery during the Japan G20 presidency, with the engagement of those who benefitted most from globalisation including the financial services industry in creating new health-related financial instruments.

Engage with the 2019 G20 Presidency of Japan and the G7 under France to promote the best practices and operational-, economic- and partnership models in innovative product development, delivery and finance to ensure better health for all throughout the G20 and globally.

Ensure G20 Leaders recognise that the development of new medical instruments, innovation also needs to address vulnerable populations including in the development of paediatric friendly formulations.